Literature DB >> 15328420

BSR Biologics Registry.

I Griffiths, A Silman, D Symmons, D G I Scott.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15328420     DOI: 10.1093/rheumatology/keh356

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  5 in total

Review 1.  Biologic therapies: what and when?

Authors:  Sarah L Johnston
Journal:  J Clin Pathol       Date:  2007-01       Impact factor: 3.411

2.  The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines.

Authors:  Christine Y Lu; Kenneth M Williams; Richard O Day
Journal:  Aust New Zealand Health Policy       Date:  2007-03-01

3.  Avoiding pitfalls when combining multiple imputation and propensity scores.

Authors:  Emily Granger; Jamie C Sergeant; Mark Lunt
Journal:  Stat Med       Date:  2019-09-11       Impact factor: 2.373

4.  Different methods of balancing covariates leading to different effect estimates in the presence of effect modification.

Authors:  Mark Lunt; Daniel Solomon; Kenneth Rothman; Robert Glynn; Kimme Hyrich; Deborah P M Symmons; Til Stürmer
Journal:  Am J Epidemiol       Date:  2009-01-19       Impact factor: 4.897

5.  Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies.

Authors:  W G Dixon; D P M Symmons; M Lunt; K D Watson; K L Hyrich; A J Silman
Journal:  Arthritis Rheum       Date:  2007-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.